View recent announcements and news releases related to Providence ResearchTo read the full article, please click on the article title.
The funding will support the renewal of the CIHR Canadian HIV Trials Network (CTN), whose National Centre is based at St. Paul’s.
Dr. Zachary Laksman, a specialist in heart-rhythm disorders at Providence Health Care and Principal Investigator with the Centre for Heart Lung Innovation, has been named a Recipient of Canada’s Top 40 Under 40 for 2019.
Providence Health research group receives federal funds to support survivors of gender-based violence
The federal government is providing $1 million to the Centre for Gender and Sexual Health Equity for a project to to support survivors of gender-based violence in Vancouver.
Dr. Don Sin, staff respirologist at St. Paul’s Hospital and the Head of Respiratory Medicine at Providence Health Care, discusses the effects of smoke on our health.
The Providence Health Care research community converged on the Century Plaza Hotel June 7 for a morning of celebration, education and networking.
Dr. James and Robert Hogg both have deep connections to Providence Health Care, are both renowned researchers in their respective fields and are both recipients of the Order of Canada.
A recent European study that concluded women have lower chances than men of surviving a cardiac arrest outside of a hospital is consistent with the work of two Providence Health Care researchers.
Findings from a sweeping global study conducted by Dr. Scott Lear, among others, reveal a direct correlation between socioeconomic status and one’s susceptibility to heart attacks and strokes.
Federal Health Minister Ginette Pettipas Taylor made the announcement as part of the international conference on gender equity, Women Deliver being held in Vancouver.
For many people with chronic obstructive pulmonary disease or COPD, a steroid inhaler is a daily necessity to keep their airways open and help them to breathe. Now, a new UBC analysis shows that these medicated devices may also reduce patients’ risk of lung cancer by as much as 30 per cent.